Work

Abstract CT106: First-Line mRNA-4359 plus pembrolizumab (pembro) in locally advanced or metastatic melanoma: Results from the phase 1/2 mRNA-4359-P101 study

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-ct106

Authors: Pavlina Spiliopoulou, Adnan Khattak, Theresa Medina, Ioannis Karydis, Debashis Sarker, David J. Pinato, Gary W. Middleton, Ryan J. Sullivan, Mark R. Middleton, Hikmat N. Daghestani, Michael Abadier, Xuezhou Mao, Ferdous Barlaskar, Georgina V. Long

Institutions: University of Glasgow, Edith Cowan University, Hollywood Private Hospital, University Hospital Southampton NHS Foundation Trust, University of Southampton, Guy's Hospital, King's College London, Hammersmith Hospital, Imperial College London, University of Birmingham, Massachusetts General Hospital, The University of Sydney, Royal North Shore Hospital, Melanoma Institute Australia

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154697590

Cites:

Cited by:

Related to: